v1
A phase II study of doxorubicin, cisplatin, and 5-fluorouracil in patients with advanced adenocarcinoma of the stomach or esophagus.
Identifier:nobleid.org/w1/20260515/CF239C23
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/CF239C23)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →